Apellis Pharmaceuticals Aktie
17,14
EUR
-0,22
EUR
-1,27
%
19,73
USD
-0,37
USD
-1,84
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
| 01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
| 24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung